Yzilan

Medicinal product

(Invented) name

Yzilan

Active substance (s)

Rabeprazolo natrio druska

Strength

10 mg

Pharmaceutical form

skrandyje neirios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A02BC04, Rabeprazole

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2016-08-02

Date of renewal

2021-08-13

Documents

3947 Yzilan RPP 2022 08 30.docx

3947 Pakuotės lapelis 2022 08 30.docx

Rabeprazole_Ingen_Pharma_AR.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Rabeprazolo natrio druska	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
63284	77701	1077701	lizdinė plokštelė	N14		Receptinis	LT/1/16/3947/001	Netiekiama	-	-	No	-	-
66105	80627	1080627	lizdinė plokštelė	N28		Receptinis	LT/1/16/3947/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-08-13	Perregistruotas
2016-08-02	Registruotas